Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 5703 (miR-5703, also known as hsa-mir-5703 or MIR5703) is a small, non-coding RNA molecule belonging to the microRNA family, which functions chiefly in the post-transcriptional regulation of gene expression. miR-5703 directly targets messenger RNAs to repress translation or induce degradation, impacting cellular pathways. Specifically, miR-5703 is implicated in suppressing tumor growth and metastasis in liver cancer by downregulating the SRC-FAK-FOXO1 axis and influencing cell proliferation and migration[1]. In ovarian carcinoma, miR-5703 is aberrantly expressed in cancer stem-like spheres and is considered a candidate biomarker for these cell populations; its precise functional effects in tumor development and progression remain to be fully characterized[2]. There is currently no evidence that miR-5703 is the direct target of any clinically approved drugs, nor that it is used as a biomarker in standard clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 5703 (miR-5703).